Article
AAVR: A Multi-Serotype Receptor for AAV
1 Apr 2016
Abstract excerpt
Adeno-associated virus (AAV) continues to be a promising viral vector for delivery of therapeutic genes in human gene therapy. In 2012, the European Commission approved Glybera (alipogene tiparvovec),1 an AAV vector carrying the human lipoprotein lipase gene for commercial use in treatment of lipoprotein lipase deficiency. In addition, within the past five years there have been numerous successes in preclinical,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
